Neuronal activity in the globus pallidus of multiple system atrophy patients

Movement Disorders

Volumn 19, Issue 12, 2004, Pages 1485-1492

  Pereira, Luiz C M ^a   Palter, Vanessa N ^a   Lang, Anthony E ^a,b   Hutchinson, William D ^a,b   Lozano, Andres M ^a,b   Dostrovsky, Jonathan O ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

BG; Globus pallidus; MSA; PD; Recordings

Indexed keywords

AMANTADINE; AMITRIPTYLINE; BROMOCRIPTINE; DIAZEPAM; DOMPERIDONE; LEVODOPA; OXAZEPAM; PERGOLIDE; SELEGILINE;

ADULT; AGED; ARTICLE; BRAIN NERVE CELL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREQUENCY ANALYSIS; GLOBUS PALLIDUS; HUMAN; MALE; MICROELECTRODE; NERVE CELL MEMBRANE STEADY POTENTIAL; PALLIDOTOMY; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECORDING; SHY DRAGER SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; ANTICONVULSANTS; ANTIPARKINSON AGENTS; FEMALE; GLOBUS PALLIDUS; HUMANS; LEVODOPA; MALE; MICROELECTRODES; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE;

EID: 12144270353     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20236     Document Type: Article

References (53)

1. Wenning GK, Granata R. Multiple system atrophy: more on the nature of the beast. Neurologia 1998;13:105-110.
2. Litvan I. Parkinsonian features: when are they Parkinson disease? JAMA 1998;280:1654-1655.
3. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;(Suppl.):78-89.
4. Bower JH, Maraganore DM, McDonnell SK, Rocca WA. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology 1997;49:1284-1288.
5. Schrag A, Ben Shlomo Y, Quinn NP. Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study. Lancet 1999;354:1771-1775.
6. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
7. Maurer JT, Juncker C, Baker-Schreyer A, Hormann K. [Sleep apnea syndromes in multiple system atrophy.] HNO 1999;47:117-121.
8. Testa D, Filippini G, Farinotti M, Palazzini E, Caraceni T. Survival in multiple system atrophy: a study of prognostic factors in 59 cases. J Neurol 1996;243:401-404.
9. Wenning GK, Ben Shlomo Y, Magalhaes M, Daniel SE, Quinn NP. Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994;117:835-845.
10. Lang AE, Lozano A, Duff J, et al. Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration. Adv Neurol 1997;74:199-211.
11. Hutchison WD, Lozano AM, Davis KD, Saint-Cyr JA, Lang AE, Dostrovsky JO. Differential neuronal activity in segments of globus pallidus in Parkinson's disease patients. Neuroreport 1994;5: 1533-1537.
12. Lozano A, Hutchison W, Kiss Z, Tasker R, Davis K, Dostrovsky J. Methods for microelectrode-guided posteroventral pallidotomy. J Neurosurg 1996;84:194-202.
13. Schaltenbrand G, Wahren W. Atlas for stereotaxy of the human brain. Stuttgart: Theime; 1997.
14. Lozano AM, Lang AE, Hutchison WD, Dostrovsky JO. Microelectrode recording-guided posteroventral pallidotomy in patients with Parkinson's disease. Adv Neurol 1997;74:167-174.
15. Hutchison WD, Levy R, Dostrovsky JO, Lozano AM, Lang AE. Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann Neurol 1997;42:767-775.
16. Obeso JA, Rodriguez MC, DeLong MR. Basal ganglia pathophysiology. A critical review. Adv Neurol 1997;74:3-18.
17. Hutchison WD, Lang AE, Dostrovsky JO, Lozano AM. Pallidal neuronal activity: implications for models of dystonia. Ann Neurol 2003;53:480-488.
18. Dostrovsky JO, Tang J, Lozano AM, Hutchison WD. Altered pattern of neuronal firing in pallidal neurons in Huntington's and Parkinson's disease patients. Program No. 390.2. Abstract. Washington, DC: Society for Neuroscience; 2003.
19. Sung JH, Mastri AR, Segal E. Pathology of Shy-Drager syndrome. J Neuropathol Exp Neurol 1979;38:353-368.
20. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-1842.
21. Andrews JM, Terry RD, Spataro J. Striatonigral degeneration. Clinical-pathological correlations and response to stereotaxic surgery. Arch Neurol 1970;23:319-329.
22. Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979;43:59-82.
23. Borit A, Rubinstein LJ, Urich H. The striatonigral degenerations. Putaminal pigments and nosology. Brain 1975;98:101-112.
24. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-2301.
25. Goto S, Hirano A, Matsumoto S. Subdivisional involvement of nigrostriatal loop in idiopathic Parkinson's disease and striatonigral degeneration. Ann Neurol 1989;26:766-770.
26. Wenning GK, Tison F, Ben Shlomo Y, Daniel SE, Quinn NP. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord 1997;12:133-147.
27. Goto S, Hirano A, Rojas-Corona RR. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta Neuropathol (Berl) 1989;78:543-550.
28. Goto S, Matsumoto S, Ushio Y, Hirano A. Subregional loss of putaminal efferents to the basal ganglia output nuclei may cause parkinsonism in striatonigral degeneration. Neurology 1996;47: 1032-1036.
29. Ito H, Goto S, Sakamoto S, Hirano A. Calbindin-D28k in the basal ganglia of patients with parkinsonism. Ann Neurol 1992;32:543-550.
30. Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 1988;318:876-880.
31. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp Neurol 1999;158:135-142.
32. Hardman CD, Halliday GM. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy. Mov Disord 1999;14:626-633.
33. Parati EA, Fetoni V, Geminiani GC, et al. Response to L-dopa in multiple system atrophy. Clin Neuropharmacol 1993;16:139-144.
34. Ito H, Kusaka H, Matsumoto S, Imai T. Striatal efferent involvement and its correlation to levodopa efficacy in patients with multiple system atrophy. Neurology 1996;47:1291-1299.
35. Filion M, Tremblay L. Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:142-151.
36. van Royen E, Verhoeff NF, Speelman JD, Wolters EC, Kuiper MA, Janssen AG. Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography. Arch Neurol 1993;50:513-516.
37. Antonini A, Leenders KL, Vontobel P, et al. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997;120:2187-2195.
38. Schulz JB, Klockgether T, Petersen D, et al. Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-1056.
39. Shinotoh H, Inoue O, Hirayama K, et al. Dopamine D1 receptors in Parkinson's disease and striatonigral degeneration: a positron emission tomography study. J Neurol Neurosurg Psychiatry 1993; 56:467-472.
40. Brooks DJ, Ibanez V, Sawle GV, et al. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192.
41. Mink JW, Thach WT. Basal ganglia intrinsic circuits and their role in behavior. Curr Opin Neurobiol 1993;3:950-957.
42. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995;20:128-154.
43. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
44. Lang AE, Lozano A, Montgomery EB, Tasker RR, Hutchison WD. Posteroventral medial pallidotomy in advanced Parkinson's disease. Adv Neurol 1999;80:575-583.
45. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
46. Volkmann J, Sturm V, Weiss P, et al. Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 1998;44:953-961.
47. Pinter MM, Alesch F, Murg M, Helscher RJ, Binder H. Apomorphine test: a predictor for motor responsiveness to deep brain stimulation of the subthalamic nucleus. J Neurol 1999;246:907-913.
48. Berciano J, Valldeoriola F, Ferrer I, Rumia J, Pascual J, Marin C, Rey MJ, Tolosa E. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002;17:812-816.
49. Tarsy D, Apetauerova D, Ryan P, Norregaard T. Adverse effects of subthalamic nucleus DBS in a patient with multiple system atrophy. Neurology 2003;61:247-249.
50. Visser-Vandewalle V, Temel Y, Colle H, van der Linden C. Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy - parkinsonism. Report of four cases. J Neurosurg 2003;98:882-887.
51. Anderson ME, Postupna N, Ruffo M. Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey. J Neurophysiol 2003;89: 1150-1160.
52. Hashimoto T, Elder CM, Okun MS, Patrick SK, Vitek JL. Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J Neurosci 2003;23:1916-1923.
53. Ni Z, Bouali-Benazzouz R, Gao D, Benabid AL, Benazzouz A. Changes in the firing pattern of globus pallidus neurons after the degeneration of nigrostriatal pathway are mediated by the subthalamic nucleus in the rat. Eur J Neurosci 2000;12:4338-4344.